Tag: Mark Womack
BioCina secures funding to develop manufacturing tech for mRNA vaccine
Australian contract development and manufacturing organisation (CDMO) BioCina has received an AUD 5 million grant under the Federal Government's Medical Research Future Fund (MRFF) Grants scheme to develop enabling technologies for the manufacture of precision mRNA vaccines.
BioCina taps Mark Womack as CEO
Australian contract development and manufacturing organisation (CDMO) BioCina has appointed Mark Womack as the chief executive officer who will be responsible for the continued growth, commercial strategy and organisational culture of the company.
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
